Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tepilta for radiation-induced oesophagitis
2009-014441-93Phase 3Completed
- Sponsor
- Meda
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Tepilta in radiation esophagitis (4 arms), sponsored by Meda. Started May 2010; status: completed.
02
Drugs
Tepilta
03
Conditions
radiation esophagitis
Beyond the preview
Go deeper on 2009-014441-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014441-93.